Mechanistic studies and analyses of larger patient cohorts will provide deeper insights into GLIPR2’s functional relevance in NSCLC pathobiology, potentially guiding personalized therapeutic strategies. Here, GLIPR2 is linked to non-small cell lung carcinoma.